Literature DB >> 17545732

Heritability of magnetic resonance imaging (MRI) traits in Alzheimer disease cases and their siblings in the MIRAGE study.

Kathryn L Lunetta1, Porat M Erlich, Karen T Cuenco, L Adrienne Cupples, Robert C Green, Lindsay A Farrer, Charles Decarli.   

Abstract

Magnetic resonance imaging (MRI) traits can serve as more specific measures of degenerative or cerebrovascular brain injury than can be ascertained through personal history, risk factors, clinical signs, or symptoms. They are potentially useful intermediate phenotypes for genetic studies of Alzheimer disease (AD). Recent studies have estimated heritability of white matter hyperintensity (WMH) among cognitively normal family members to be between 0.55 and 0.73. Persons discordant for AD are expected to have substantially different MRI phenotype distributions; our goal was to determine whether MRI traits in siblings discordant for AD are heritable. We measured cerebral atrophy, medial temporal atrophy (MTA), WMH, and a rating of cerebrovascular disease (CVR) via MRI in 815 participants from 424 families of the Multi-Institutional Research in Alzheimer's Genetic Epidemiology Study. Residual heritability after adjustment for covariates ranged from 0.17 (P=0.009) for MTA to 0.57 (P=10(-7)) for CVR. The number of APOE-epsilon4 alleles was significantly associated with WMH (P=0.01) and CVR (P=0.005) but not cerebral atrophy (P=0.25) or MTA (P=0.83). Heritability remained significant and high after adjusting for APOE genotype, suggesting that a substantial proportion of the additive genetic variation in these MRI traits is explained by other genes. In the Multi-Institutional Research in Alzheimer's Genetic Epidemiology Study of AD-discordant siblings, MRI traits are heritable and are potential endophenotypes for genetic association studies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17545732     DOI: 10.1097/WAD.0b013e3180653bf7

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  19 in total

Review 1.  Genetic architecture of declarative memory: implications for complex illnesses.

Authors:  Carrie E Bearden; Katherine H Karlsgodt; Peter Bachman; Theo G M van Erp; Anderson M Winkler; David C Glahn
Journal:  Neuroscientist       Date:  2011-08-10       Impact factor: 7.519

Review 2.  Vascular basis for brain degeneration: faltering controls and risk factors for dementia.

Authors:  Raj N Kalaria
Journal:  Nutr Rev       Date:  2010-12       Impact factor: 7.110

3.  Head circumference, atrophy, and cognition: implications for brain reserve in Alzheimer disease.

Authors:  R Perneczky; S Wagenpfeil; K L Lunetta; L A Cupples; R C Green; C Decarli; L A Farrer; A Kurz
Journal:  Neurology       Date:  2010-07-13       Impact factor: 9.910

4.  Multiple loci influencing hippocampal degeneration identified by genome scan.

Authors:  Scott A Melville; Jacqueline Buros; Antonio R Parrado; Badri Vardarajan; Mark W Logue; Li Shen; Shannon L Risacher; Sungeun Kim; Gyungah Jun; Charles DeCarli; Kathryn L Lunetta; Clinton T Baldwin; Andrew J Saykin; Lindsay A Farrer
Journal:  Ann Neurol       Date:  2012-06-28       Impact factor: 10.422

5.  Family history of Alzheimer's disease and hippocampal structure in healthy people.

Authors:  Markus Donix; Alison C Burggren; Nanthia A Suthana; Prabha Siddarth; Arne D Ekstrom; Allison K Krupa; Michael Jones; Laurel Martin-Harris; Linda M Ercoli; Karen J Miller; Gary W Small; Susan Y Bookheimer
Journal:  Am J Psychiatry       Date:  2010-08-04       Impact factor: 18.112

6.  Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy.

Authors:  A Biffi; A Halpin; A Towfighi; A Gilson; K Busl; N Rost; E E Smith; M S Greenberg; J Rosand; A Viswanathan
Journal:  Neurology       Date:  2010-08-24       Impact factor: 9.910

Review 7.  APOE genotype and MRI markers of cerebrovascular disease: systematic review and meta-analysis.

Authors:  Sabrina Schilling; Anita L DeStefano; Perminder S Sachdev; Seung Hoan Choi; Karen A Mather; Charles D DeCarli; Wei Wen; Peter Høgh; Naftali Raz; Rhoda Au; Alexa Beiser; Philip A Wolf; José Rafael Romero; Yi-Cheng Zhu; Kathryn L Lunetta; Lindsay Farrer; Carole Dufouil; Lewis H Kuller; Bernard Mazoyer; Sudha Seshadri; Christophe Tzourio; Stéphanie Debette
Journal:  Neurology       Date:  2013-07-16       Impact factor: 9.910

Review 8.  A focus on structural brain imaging in the Alzheimer's disease neuroimaging initiative.

Authors:  Meredith N Braskie; Paul M Thompson
Journal:  Biol Psychiatry       Date:  2013-11-28       Impact factor: 13.382

9.  Regional white matter hyperintensities: aging, Alzheimer's disease risk, and cognitive function.

Authors:  Alex C Birdsill; Rebecca L Koscik; Erin M Jonaitis; Sterling C Johnson; Ozioma C Okonkwo; Bruce P Hermann; Asenath Larue; Mark A Sager; Barbara B Bendlin
Journal:  Neurobiol Aging       Date:  2013-10-10       Impact factor: 4.673

10.  Association of TTR polymorphisms with hippocampal atrophy in Alzheimer disease families.

Authors:  Karen T Cuenco; Robert Friedland; Clinton T Baldwin; Jianping Guo; Badri Vardarajan; Kathryn L Lunetta; L Adrienne Cupples; Robert C Green; Charles DeCarli; Lindsay A Farrer
Journal:  Neurobiol Aging       Date:  2009-03-27       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.